Trial Profile
RG 7128 effects on QT interval prolongation in volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 08 Feb 2018
Price :
$35
*
At a glance
- Drugs Mericitabine (Primary) ; Moxifloxacin
- Indications Hepatitis C
- Focus Adverse reactions
- Sponsors Roche
- 03 Apr 2011 Results presented at the 46th Annual Meeting of the European Association for the Study of the Liver.
- 01 Apr 2011 New trial record